Exosomics implements NanoFCMs NanoAnalyzer at its Siena facility

Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility

Exosomics SpA, the leading extracellular vesicles biotech company, has announced that it has implemented NanoFCM Co., Ltd’s NanoAnalyzer instrument to offer sophisticated contract research and measurement services worldwide. In this strategic partnership, Exosomics becomes NanoFCM’s approved service supplier of nano-flow cytometry measurements. These can be performed as stand-alone or coupled to solutions provided by Exosomics....

Original Article: Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility

More From BioPortfolio on "Exosomics implements NanoFCM’s NanoAnalyzer at its Siena facility"